MeiraGTx Holdings plc (MGTX)
NASDAQ$7.77
Market Cap
$612.7M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
72 of 924
Rank in Industry
51 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
MGTX Insider Trading Activity
MGTX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $5,000,000 | 1 | 25 |
Sells | $456,303 | 3 | 75 |
Related Transactions
| PERCEPTIVE ADVISORS LLC | 1 | $5M | 0 | $0 | $5M | |
| Giroux Richard | CFO & COO | 0 | $0 | 1 | $150,960 | $-150,960 |
| Forbes Alexandria | PRESIDENT & CEO | 0 | $0 | 2 | $305,343 | $-305,343 |
About MeiraGTx Holdings plc
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, …
Insider Activity of MeiraGTx Holdings plc
Over the last 12 months, insiders at MeiraGTx Holdings plc have bought $5M and sold $456,303 worth of MeiraGTx Holdings plc stock.
On average, over the past 5 years, insiders at MeiraGTx Holdings plc have bought $10.71M and sold $4.12M worth of stock each year.
Highest buying activity among insiders over the last 12 months: PERCEPTIVE ADVISORS LLC () — $5M.
The last purchase of 1,250,000 shares for transaction amount of $5M was made by PERCEPTIVE ADVISORS LLC () on 2024‑08‑12.
List of Insider Buy and Sell Transactions, MeiraGTx Holdings plc
| 2025-01-21 | Sale | Giroux Richard | CFO & COO | 24,000 0.0304% | $6.29 | $150,960 | +3.51% | |
| 2025-01-08 | Sale | Forbes Alexandria | PRESIDENT & CEO | 11,661 0.0148% | $6.30 | $73,464 | +1.73% | |
| 2025-01-07 | Sale | Forbes Alexandria | PRESIDENT & CEO | 35,839 0.0469% | $6.47 | $231,878 | +1.66% | |
| 2024-08-12 | PERCEPTIVE ADVISORS LLC | 1.25M 1.9341% | $4.00 | $5M | +52.25% | |||
| 2023-05-05 | PERCEPTIVE ADVISORS LLC | 4.35M 8.3577% | $5.75 | $25M | -2.03% | |||
| 2022-06-03 | Zeldin Robert K | CHIEF MEDICAL OFFICER | 6 <0.0001% | $7.89 | $47 | -6.73% | ||
| 2022-05-25 | Wollin Robert J | GENERAL COUNSEL AND SECRETARY | 1,000 0.0022% | $7.94 | $7,940 | -5.28% | ||
| 2021-11-17 | Sale | Forbes Alexandria | President and CEO | 30,000 0.0679% | $19.86 | $595,800 | -51.18% | |
| 2021-11-16 | Sale | Forbes Alexandria | President and CEO | 30,000 0.0678% | $19.97 | $599,144 | -51.10% | |
| 2021-10-20 | Sale | Giroux Richard | CFO & COO | 41,400 0.0941% | $21.05 | $871,371 | -40.21% | |
| 2021-10-19 | Sale | Giroux Richard | CFO & COO | 2,600 0.0062% | $20.07 | $52,182 | -33.88% | |
| 2021-10-18 | Sale | Forbes Alexandria | President and CEO | 60,000 0.1271% | $17.36 | $1.04M | -31.36% | |
| 2021-10-18 | Sale | Naylor Stuart | Chief Development Officer | 24,000 0.0526% | $17.95 | $430,800 | -31.36% | |
| 2021-07-20 | Sale | Naylor Stuart | Chief Development Officer | 18,780 0.0419% | $15.06 | $282,827 | -10.03% | |
| 2021-07-13 | Sale | Naylor Stuart | Chief Development Officer | 5,220 0.0119% | $15.04 | $78,509 | -6.75% | |
| 2021-06-09 | Sale | Forbes Alexandria | President and CEO | 8,306 0.0187% | $15.04 | $124,922 | -6.21% | |
| 2021-06-08 | Sale | Forbes Alexandria | President and CEO | 40,360 0.0917% | $15.02 | $606,207 | -5.14% | |
| 2021-06-08 | Sale | Naylor Stuart | Chief Development Officer | 10,080 0.0229% | $15.01 | $151,301 | -5.14% | |
| 2021-06-07 | Sale | Forbes Alexandria | President and CEO | 11,334 0.026% | $15.03 | $170,350 | -4.05% | |
| 2021-06-07 | Sale | Naylor Stuart | Chief Development Officer | 2,084 0.0048% | $15.02 | $31,302 | -4.05% |
Total: 67
*Gray background shows transactions not older than one year
Insider Historical Profitability
<0.0001%
| PERCEPTIVE ADVISORS LLC | 12531103 15.8913% | $97.37M | 6 | 0 | <0.0001% | |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 10 percent owner | 6007746 7.6187% | $46.68M | 1 | 0 | +18.44% |
| Seligman Nicole | director | 5000 0.0063% | $38,850.00 | 1 | 0 | <0.0001% |
| Zeldin Robert K | CHIEF MEDICAL OFFICER | 5000 0.0063% | $38,850.00 | 1 | 0 | <0.0001% |
| Wollin Robert J | GENERAL COUNSEL AND SECRETARY | 1000 0.0013% | $7,770.00 | 1 | 0 | <0.0001% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$3,596,906 | 112 | 13.42% | $665.63M | |
$36,510,315 | 95 | 8.95% | $611.9M | |
$678,065,999 | 37 | -13.32% | $608.58M | |
$94,912,877 | 34 | -7.15% | $601.56M | |
$149,456,352 | 27 | -8.77% | $712.19M |
MGTX Institutional Investors: Active Positions
| Increased Positions | 60 | +64.52% | 15M | +33.97% |
| Decreased Positions | 38 | -40.86% | 2M | -5.47% |
| New Positions | 17 | New | 14M | New |
| Sold Out Positions | 15 | Sold Out | 839,341 | Sold Out |
| Total Postitions | 115 | +23.66% | 58M | +28.5% |
MGTX Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Perceptive Advisors Llc | $98,007.00 | 16.13% | 12.58M | 0 | 0% | 2024-12-31 |
| Sanofi | $95,020.00 | 15.64% | 12.2M | +12M | New | 2024-12-31 |
| Johnson & Johnson | $51,734.00 | 8.51% | 6.64M | 0 | 0% | 2024-12-31 |
| Adage Capital Partners Gp, L.L.C. | $39,219.00 | 6.46% | 5.03M | -194,521 | -3.72% | 2024-12-31 |
| Prosight Management, Lp | $34,205.00 | 5.63% | 4.39M | -509,733 | -10.4% | 2024-12-31 |
| Blackrock, Inc. | $23,148.00 | 3.81% | 2.97M | +284,774 | +10.6% | 2024-12-31 |
| 683 Capital Management, Llc | $18,813.00 | 3.1% | 2.42M | -135,000 | -5.29% | 2024-12-31 |
| Woodline Partners Lp | $11,959.00 | 1.97% | 1.54M | +2M | New | 2024-12-31 |
| Knoll Capital Management, Llc | $9,738.00 | 1.6% | 1.25M | 0 | 0% | 2024-12-31 |
| Erste Asset Management Gmbh | $5,217.00 | 0.86% | 669,702 | 0 | 0% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.